Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Putting together the pieces: CAR into CD3ζ locus

Monica Casucci

Blood (2024) 143 (25): 2562–2564.

https://doi.org/10.1182/blood.2024024491

Published: 2024

Journal Articles

CAR-T Cells for Systemic Lupus Erythematosus

Matteo Doglio, Alessia Ugolini, Clara Bercher, Cristiano Toma, Chiara Bonini, Fabio Ciceri, Barbara Camisa, Rossana Norata, Stefania Del Rosso, Francesca Sanvito, Monica Casucci, Angelo Manfredi

Blood (2023) 142 (Supplement 1): 6813.

https://doi.org/10.1182/blood-2023-189673

Published: 2023

Journal Articles

A second CD19 CAR T-cell infusion: yes or no?

Monica Casucci, Fabio Ciceri

Blood (2021) 137 (3): 284–286.

https://doi.org/10.1182/blood.2020009206

Published: 2021

Journal Articles

Combining De-Glycosylating Agents with CAR-T Cells for Targeting Solid Tumors and Reducing Toxicity

Beatrice Greco, MSc, Katia Paolella, Barbara Camisa, Valeria Malacarne, PhD, Laura Falcone, Andrea Graziani, PhD, Chiara Bonini, MD, Attilio Bondanza, MD, Monica Casucci, PhD

Blood (2018) 132 (Supplement 1): 4544.

https://doi.org/10.1182/blood-2018-99-116019

Published: 2018

Journal Articles

Exhausted Central Memory and Memory Stem T Cells Specific for Leukemia Infiltrate the Bone Marrow of AML Patients Relapsing after Allogeneic HSCT

Francesco Manfredi, MD, Maddalena Noviello, PhD, Eliana Ruggiero, PhD, Tommaso Perini, MD, Giacomo Oliveira, PhD, Filippo Cortesi, PhD, Pantaleo De Simone, MD, Cristina Toffalori, Valentina Gambacorta, MSc, Raffaella Greco, MD, Jacopo Peccatori, Monica Casucci, PhD, Giulia Casorati, PhD, Paolo Dellabona, MD PhD, Nicoletta Cieri, MD PhD, Attilio Bondanza, MD, Luca Vago, MD PhD, Fabio Ciceri, MD, Chiara Bonini, MD

Blood (2018) 132 (Supplement 1): 2028.

https://doi.org/10.1182/blood-2018-99-118104

Published: 2018

Journal Articles

Phase I-IIa Clinical Trial to Assess Safety and Efficacy of MLM-CAR44.1, a CD44v6 Directed CAR-T in Relapsed/Refractory Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Matteo Giovanni Carrabba, MD, Monica Casucci, PhD, Michael Hudecek, MD, Concetta Quintarelli, PhD, Javier Briones, MD, Roman Hajek, MD PhD, Jorge Sierra, MD, Franco Locatelli, Hermann Einsele, MD PhD, Claudio Bordignon, MD, Fabio Ciceri, MD, Catia Traversari, PhD

Blood (2018) 132 (Supplement 1): 5790.

https://doi.org/10.1182/blood-2018-99-117974

Published: 2018

Journal Articles

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease

Blood (2017) 130 (5): 606–618.

https://doi.org/10.1182/blood-2016-08-732636

Published: 2017

Includes: Supplemental data

Journal Articles

Monocytes Are Required for Both Optimal Anti-Leukemic Efficacy and the Cytokine Release Syndrome By CAR-T Cells: Lessons from an Innovative Xenotolerant Mouse Model

Margherita Norelli, MSc, Monica Casucci, PhD, Barbara Camisa, BSc, Laura Falcone, MSc, Catia Traversari, PhD, Claudio Bordignon, MD, Fabio Ciceri, MD, Chiara Bonini, MD, Attilio Bondanza, MD PhD

Blood (2016) 128 (22): 997.

https://doi.org/10.1182/blood.V128.22.997.997

Published: 2016

Journal Articles

Off-Tumor Target Expression Levels Do Not Predict CAR-T Cell Killing: A Foundation For The Safety Of CD44v6-Targeted T Cells

Monica Casucci, PhD, Benedetta Nicolis di Robilant, MSc, Laura Falcone, MSc, Barbara Camisa, BSc, Margherita Norelli, Bsc, Bernhard Gentner, MD, Pietro Genovese, PhD, Maurilio Ponzoni, MD, Aurore Saudemont, PhD, Claudio Bordignon, MD, Luigi Naldini, MD, PhD, Fabio Ciceri, MD, Gianpietro Dotti, MD, Chiara Bonini, MD, Attilio Bondanza, MD, PhD

Blood (2013) 122 (21): 142.

https://doi.org/10.1182/blood.V122.21.142.142

Published: 2013

Journal Articles

CD44v6 Is Required For In Vivo Tumorigenesis Of Human AML and MM Cells: Role Of Microenvironmental Signals and Therapeutic Implications

Benedetta Nicolis di Robilant, MSc, Monica Casucci, PhD, Laura Falcone, MSc, Barbara Camisa, BSc, Bernhard Gentner, MD#, Luigi Naldini, MD, PhD#, Claudio Bordignon, MD, Fabio Ciceri, MD, Chiara Bonini, MD, Attilio Bondanza, MD, PhD

Blood (2013) 122 (21): 605.

https://doi.org/10.1182/blood.V122.21.605.605

Published: 2013

Journal Articles

CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma

Monica Casucci, Benedetta Nicolis di Robilant, Laura Falcone, Barbara Camisa, Margherita Norelli, Pietro Genovese, Bernhard Gentner, Fabiana Gullotta, Maurilio Ponzoni, Massimo Bernardi, Magda Marcatti, Aurore Saudemont, Claudio Bordignon, Barbara Savoldo, Fabio Ciceri, Luigi Naldini, Gianpietro Dotti, Chiara Bonini, Attilio Bondanza

Blood (2013) 122 (20): 3461–3472.

https://doi.org/10.1182/blood-2013-04-493361

Published: 2013

Includes: Supplemental data

Journal Articles

Co-Expression of a Suicide Gene in CAR-Redirected T Cells Enables the Safe Targeting of CD44v6 for Leukemia and Myeloma Eradication

Monica Casucci, PhD, Benedetta Nicolis di Robilant, MSc, Laura Falcone, MSc, Barbara Camisa, BSc, Pietro Genovese, PhD, Bernhard Gentner, MD $, Luigi Naldini, MD, PhD, Barbara Savoldo, MD, PhD, Fabio Ciceri, MD, Claudio Bordignon, MD, Gianpietro Dotti, MD, Chiara Bonini, MD, Attilio Bondanza, MD, PhD

Blood (2012) 120 (21): 949.

https://doi.org/10.1182/blood.V120.21.949.949

Published: 2012

Journal Articles

Dual Transgenesis of T Cells with a Novel CD44v6-Specific Chimeric Antigen Receptor and a Suicide Gene for Safe and Effective Targeting of Chemoresistance in Hematopoietic Tumors

Monica Casucci, Laura Falcone, Benedetta Nicolis di Robilant, Barbara Camisa, BSc, Pietro Genovese, Bernhard Gentner, MD, Luigi Naldini, MD, PhD, Barbara Savoldo, Fabio Ciceri, M.D., Claudio Bordignon, MD, Gianpietro Dotti, MD, Chiara Bonini, Attilio Bondanza, MD, PhD

Blood (2011) 118 (21): 3125.

https://doi.org/10.1182/blood.V118.21.3125.3125

Published: 2011

Journal Articles

Leukemic Dendritic Cells Expand Central Memory T Lymphocytes From HCT Donors Able to React against the Original Leukemia in Vitro and In Vivo.

Monica Casucci, Serena Kimi Perna, Attilio Bondanza, Zulma Magnani, Massimo Bernardi, Alessandro Crotta, Cristina Tresoldi, Katharina Fleischhauer, Elena Provasi, Maurilio Ponzoni, Federico Caligaris-Cappio, Fabio Ciceri, Claudio Bordignon, Alessandro Cignetti, Chiara Bonini

Blood (2009) 114 (22): 4090.

https://doi.org/10.1182/blood.V114.22.4090.4090

Published: 2009

Journal Articles

Cytotoxicity Is Not Required for the Anti-Leukemia Efficacy of Human H-Y-Specific CD4+ T Lymphocytes In Vivo.

Attilio Bondanza, MD, PhD, Lothar Hambach, MD, Zohara Aghai, MSc, Monica Casucci, BSc, Bart Nijmeijer, PhD, Fabio Ciceri, MD, Chiara Bonini, MD, Els Goulmy, PhD

Blood (2009) 114 (22): 3553.

https://doi.org/10.1182/blood.V114.22.3553.3553

Published: 2009

Journal Articles

Leukemic Blasts Secondary to Myelodysplastic Syndromes Are Molecularly Programmed To Differentiate into Functionally Mature Dendritic Cells.

Serena K. Perna, MD, Monica Casucci, BSc, Attilio Bondanza, MD, PhD, Zulma Magnani, BSc, Massimo Bernardi, MD, Alessandro Crotta, MD, Alessandro Cignetti, MD, Ferderico Caligaris Cappio, MD, Fabio Ciceri, MD, Claudio Bordignon, MD, Chiara Bonini, MD

Blood (2007) 110 (11): 1801.

https://doi.org/10.1182/blood.V110.11.1801.1801

Published: 2007

NARROW

Putting together the pieces: CAR into CD3ζ locus

CAR-T Cells for Systemic Lupus Erythematosus

A second CD19 CAR T-cell infusion: yes or no?

Combining De-Glycosylating Agents with CAR-T Cells for Targeting Solid Tumors and Reducing Toxicity

Exhausted Central Memory and Memory Stem T Cells Specific for Leukemia Infiltrate the Bone Marrow of AML Patients Relapsing after Allogeneic HSCT

Phase I-IIa Clinical Trial to Assess Safety and Efficacy of MLM-CAR44.1, a CD44v6 Directed CAR-T in Relapsed/Refractory Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease

Monocytes Are Required for Both Optimal Anti-Leukemic Efficacy and the Cytokine Release Syndrome By CAR-T Cells: Lessons from an Innovative Xenotolerant Mouse Model

Off-Tumor Target Expression Levels Do Not Predict CAR-T Cell Killing: A Foundation For The Safety Of CD44v6-Targeted T Cells

CD44v6 Is Required For In Vivo Tumorigenesis Of Human AML and MM Cells: Role Of Microenvironmental Signals and Therapeutic Implications

CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma

Co-Expression of a Suicide Gene in CAR-Redirected T Cells Enables the Safe Targeting of CD44v6 for Leukemia and Myeloma Eradication

Dual Transgenesis of T Cells with a Novel CD44v6-Specific Chimeric Antigen Receptor and a Suicide Gene for Safe and Effective Targeting of Chemoresistance in Hematopoietic Tumors

Leukemic Dendritic Cells Expand Central Memory T Lymphocytes From HCT Donors Able to React against the Original Leukemia in Vitro and In Vivo.

Cytotoxicity Is Not Required for the Anti-Leukemia Efficacy of Human H-Y-Specific CD4+ T Lymphocytes In Vivo.

Leukemic Blasts Secondary to Myelodysplastic Syndromes Are Molecularly Programmed To Differentiate into Functionally Mature Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only